Archive of the journal «Russian otorhinolaryngology» - Medical scientific journal «Russian otorhinolaryngology»

Medical Scientific Journal
Russian
Otorhinolaryngology
9, Bronnitskaya Str., Saint Petersburg, 190013, Russia
Tel./Fax: (921) 922-36-77, e-mail: text@pfco.ru
 ISSN 2413-4309 (online), ISSN 1810-4800 (print)  
Rossiiskaya otorinolaringologiya
Go to content
◄◄   |   
Section: Section Reviews
Eosinophilic otitis media
A. S. Yunusov (1), V. A. Saidulaev (2), V. P. Shpotin (3), S. A. Shirshov (4)
(1) National Medical Research Center of Otolaryngology, Federal Medical and Biological Agency, Moscow, 123182, Russian Federation, (2) National Medical Research Center for Otorhinolaryngology, Federal Medical and Biological Agency of Russia, Astrakhan branch, Astrakhan, 414056, Russian Federation, (2), (3), (4) Astrakhan State Medical University, Astrakhan, 414000, Russian Federation
UDK: УДК 616.284-003.2:616.211-002-006.5:616.248:615.37
DOI: https://doi.org/10.18692/1810-4800-2026-3-115-120
ABSTRACT
Abstract. Eosinophilic otitis media (EOM) is a rare and clinically complex condition in the practice of otolaryngologists, characterized by a progressive course. Diagnosis of the disease is based on a combination of bronchial asthma and polypous rhinosinusitis, along with the presence of eosinophilic discharge in the middle ear. A distinctive feature of EOM is its relentless progression, which can lead to gradual hearing loss, up to complete deafness. This condition is typically associated with the development of sensorineural hearing loss, predominantly affecting high frequencies, and this process occurs over a shorter period compared to chronic otitis media. The rarity of this disease accounts for the absence of standardized treatment algorithms. This review summarizes current data on the etiology, pathogenesis, clinical presentation, diagnosis, and treatment of EOM. The work describes the etiology, pathogenesis, clinical symptoms, diagnostic approaches, and existing treatment regimens for eosinophilic otitis media.
Publication date:
16.06.2026
Keywords:
eosinophilic otitis media, bronchial asthma, polypous rhinosinusitis, type 2 inflammation, biologic therapy, omalizumab, dupilumab, sensorineural hearing loss
For citation:
Yunusov A. S., Saidulaev V. A., Shpotin V. P., Shirshov S. A. Eosinophilic otitis media. Russian Otorhinolaryngology. 2026;25(3):115-120. (In Russ.) https://doi.org/10.18692/1810-4800-2026-3-115-120
All rights to this publication are registered. Link to Russian Otorhinolaryngology Journal is required.
Reprinting of both individual articles and the Journal itself without the publisher`s permission is prohibited.
The Journal editors and publisher are not liable for the content and accuracy of advertising information.
© St. Petersburg Research Institute of Ear, Throat, Nose, and Speech of the Ministry of Health of Russia
© Scientific Clinical Center of Otorhinolaryngology, FMBA of Russia
Логотип журнала "Российская оториноларингология"
© Co. Ltd. Polyforum Group, 2012—
Яндекс.Метрика
Back to content